High-flow nasal cannula oxygen therapy in acute hypoxemic respiratory failure and COVID-19-related respiratory failure.

Acute respiratory failure COVID-19 High-flow nasal oxygen Oxygen support

Journal

Journal of intensive medicine
ISSN: 2667-100X
Titre abrégé: J Intensive Med
Pays: China
ID NLM: 9918539389006676

Informations de publication

Date de publication:
31 Jan 2023
Historique:
received: 30 05 2022
revised: 19 06 2022
accepted: 13 07 2022
entrez: 9 2 2023
pubmed: 10 2 2023
medline: 10 2 2023
Statut: ppublish

Résumé

Although standard oxygen face masks are first-line therapy for patients with acute hypoxemic respiratory failure, high-flow nasal cannula oxygen therapy has gained major popularity in intensive care units. The physiological effects of high-flow oxygen counterbalance the physiological consequences of acute hypoxemic respiratory failure by lessening the deleterious effects of intense and prolonged inspiratory efforts generated by patients. Its simplicity of application for physicians and nurses and its comfort for patients are other arguments for its use in this setting. Although clinical studies have reported a decreased risk of intubation with high-flow oxygen compared with standard oxygen, its survival benefit is uncertain. A more precise definition of acute hypoxemic respiratory failure, including a classification of severity based on oxygenation levels, is needed to better compare the efficiencies of different non-invasive oxygenation support methods (standard oxygen, high-flow oxygen, and non-invasive ventilation). Additionally, the respective role of each non-invasive oxygenation support method needs to be established through further clinical trials in acute hypoxemic respiratory failure, especially in severe forms.

Identifiants

pubmed: 36756183
doi: 10.1016/j.jointm.2022.07.005
pii: S2667-100X(22)00076-7
pmc: PMC9534601
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

20-26

Informations de copyright

© 2022 The Authors. Published by Elsevier B.V. on behalf of Chinese Medical Association.

Déclaration de conflit d'intérêts

Jean-Pierre Frat reports travel expenses coverage to attend scientific meetings and consulting fees from Fisher&Paykel and SOS oxygen; Laura Marchasson and François Arrivé report no conflicts of interest; Rémi Coudroy reports travel expenses coverage to attend scientific meetings from Fisher&Paykel and MSD, grants from ERS and SRLF.

Références

JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Intensive Care Med. 2015 Apr;41(4):623-32
pubmed: 25691263
JAMA. 2000 Nov 8;284(18):2361-7
pubmed: 11066187
J Appl Physiol (1985). 2017 Jan 1;122(1):191-197
pubmed: 27856714
Intensive Care Med. 2012 Oct;38(10):1573-82
pubmed: 22926653
JAMA. 2022 Feb 8;327(6):546-558
pubmed: 35072713
Lancet. 2020 Jun 6;395(10239):1763-1770
pubmed: 32442528
Anesthesiology. 1985 Dec;63(6):598-607
pubmed: 3904528
Am Rev Respir Dis. 1993 Nov;148(5):1194-203
pubmed: 8239153
JAMA. 2021 Dec 07;326(21):2161-2171
pubmed: 34874419
Thorax. 2020 Sep;75(9):805-807
pubmed: 32522764
N Engl J Med. 2013 Nov 28;369(22):2126-36
pubmed: 24283226
Eur Respir J Suppl. 2003 Nov;47:3s-14s
pubmed: 14621112
Respir Care. 2015 Oct;60(10):1369-76
pubmed: 25944940
Br J Anaesth. 2009 Dec;103(6):886-90
pubmed: 19846404
Crit Care. 2020 Nov 23;24(1):654
pubmed: 33225971
N Engl J Med. 2000 May 4;342(18):1301-8
pubmed: 10793162
Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):807-13
pubmed: 10712326
Chest. 2007 Aug;132(2):410-7
pubmed: 17573487
J Appl Physiol (1985). 2015 Jun 15;118(12):1525-32
pubmed: 25882385
Respir Care. 2010 Apr;55(4):408-13
pubmed: 20406507
Ann Intensive Care. 2020 Sep 29;10(1):125
pubmed: 32990864
Ann Intensive Care. 2021 Feb 27;11(1):37
pubmed: 33638752
Am J Respir Crit Care Med. 2018 Jan 15;197(2):204-213
pubmed: 28930478
Intensive Care Med. 2016 Feb;42(2):164-72
pubmed: 26408150
JAMA. 2021 May 4;325(17):1731-1743
pubmed: 33764378
Am J Respir Crit Care Med. 2020 Oct 15;202(8):1115-1124
pubmed: 32822208
Anaesthesia. 2008 Sep;63(9):938-40
pubmed: 18540928
Crit Care Med. 2016 Aug;44(8):e678-88
pubmed: 27002273
Am J Respir Crit Care Med. 2020 Feb 1;201(3):303-312
pubmed: 31687831
Intensive Care Med. 2012 Mar;38(3):458-66
pubmed: 22318634
Am J Respir Crit Care Med. 2022 May 15;205(10):1240-1243
pubmed: 35176213
Intensive Care Med. 2016 Jan;42(1):82-92
pubmed: 26464393
Lancet. 1946 Sep 14;2(6420):380
pubmed: 20997263
JAMA. 2016 Jun 14;315(22):2435-41
pubmed: 27179847
Crit Care. 2016 Apr 28;20(1):142
pubmed: 27160458
Lancet Respir Med. 2022 Jul;10(7):641-649
pubmed: 35325620
Am J Respir Crit Care Med. 2017 May 1;195(9):1207-1215
pubmed: 27997805
Intensive Care Med. 2020 Dec;46(12):2342-2356
pubmed: 33170331
Lancet Respir Med. 2021 Dec;9(12):1387-1395
pubmed: 34425070
Respir Res. 2020 Jul 28;21(1):198
pubmed: 32723327
Intensive Care Med. 2017 Feb;43(2):250-252
pubmed: 28074228
Intensive Care Med. 2021 Jan;47(1):60-73
pubmed: 33211135
Intensive Care Med. 2020 Dec;46(12):2226-2237
pubmed: 33201321
JAMA. 2018 Nov 27;320(20):2099-2107
pubmed: 30357270
Am J Respir Crit Care Med. 2017 Jan 1;195(1):67-77
pubmed: 27753501
Intensive Care Med. 2001 Nov;27(11):1718-28
pubmed: 11810114
JAMA. 2020 Jul 7;324(1):57-67
pubmed: 32496521
Eur Respir J. 2020 May 14;55(5):
pubmed: 32299867
JAMA. 2015 Oct 27;314(16):1711-9
pubmed: 26444879
Chest. 2020 Nov;158(5):1992-2002
pubmed: 32681847
Lancet. 1968 Dec 7;2(7580):1214-6
pubmed: 4177206
Crit Care Med. 2018 Apr;46(4):540-546
pubmed: 29271843
N Engl J Med. 2015 Jun 4;372(23):2185-96
pubmed: 25981908
Am J Respir Crit Care Med. 2017 Feb 15;195(4):438-442
pubmed: 27626833
Am J Respir Crit Care Med. 2020 Aug 15;202(4):558-567
pubmed: 32325004
Eur Respir J. 2022 Apr 14;59(4):
pubmed: 34649974
Br J Anaesth. 2011 Dec;107(6):998-1004
pubmed: 21908497
Crit Care Med. 2018 Feb;46(2):208-215
pubmed: 29099420
Eur Respir J. 2017 Aug 31;50(2):
pubmed: 28860265
Minerva Anestesiol. 2013 Dec;79(12):1344-55
pubmed: 23857440
Chest. 1995 Mar;107(3):761-8
pubmed: 7874950
Crit Care Med. 2020 Nov;48(11):e1045-e1053
pubmed: 32804790
Am J Respir Crit Care Med. 2020 Oct 1;202(7):1039-1042
pubmed: 32758000
Crit Care Med. 2016 Feb;44(2):282-90
pubmed: 26584191
N Engl J Med. 1998 Aug 13;339(7):429-35
pubmed: 9700176
Am J Respir Crit Care Med. 2017 Sep 1;196(5):590-601
pubmed: 28212050

Auteurs

Jean-Pierre Frat (JP)

Centre Hospitalier Universitaire de Poitiers, Médecine Intensive Réanimation, Poitiers 86021, France.
Centre d'Investigation Clinique 1402 ALIVE, INSERM, Université de Poitiers, Poitiers 86021, France.

Laura Marchasson (L)

Centre Hospitalier Universitaire de Poitiers, Médecine Intensive Réanimation, Poitiers 86021, France.

François Arrivé (F)

Centre Hospitalier Universitaire de Poitiers, Médecine Intensive Réanimation, Poitiers 86021, France.

Rémi Coudroy (R)

Centre Hospitalier Universitaire de Poitiers, Médecine Intensive Réanimation, Poitiers 86021, France.
Centre d'Investigation Clinique 1402 ALIVE, INSERM, Université de Poitiers, Poitiers 86021, France.

Classifications MeSH